Back to Search
SANKALP CHOUDHRI, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1184835282IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
38218(AZ)
Education
OTHER
Class of 1997
Research & Publications (20)
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
PMID 19406981·Am J Respir Crit Care Med·2009
4-observational
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
PMID 18419482·Clin Infect Dis·2008
4-observational
Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.
PMID 18342475·Diagn Microbiol Infect Dis·2008
7-preclinical
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
PMID 18279104·J Interferon Cytokine Res·2008
3-trial
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
PMID 17553812·J Antimicrob Chemother·2007
4-observational
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
PMID 16858182·Ann Surg·2006
3-trial
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome.
PMID 16721396·Eur J Clin Nutr·2006
4-observational
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
PMID 16675781·Am J Respir Crit Care Med·2006
3-trial
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
PMID 16531032·Respir Med·2006
4-observational
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
PMID 16323095·Clin Infect Dis·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3155 E SOUTHERN AVE, SUITE 203
MESA, AZ 85204 - Phone
- (480) 325-8173
Quick Facts
- NPI
- 1184835282
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile